Moleculin Biotech Inc. (MBRX)
NASDAQ · Healthcare
Moleculin Biotech Inc. Revenue 2016–2025
Moleculin Biotech Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Moleculin Biotech Inc. revenue for the quarter ending March 31, 2026 was 0.
- Moleculin Biotech Inc. revenue for the twelve months ending March 31, 2026 was 0.
- Moleculin Biotech Inc. annual revenue for 2025 was 0.
- Moleculin Biotech Inc. annual revenue for 2024 was 0.
- Moleculin Biotech Inc. annual revenue for 2023 was 0.
- Moleculin Biotech Inc. annual revenue for 2022 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
Moleculin Biotech Inc. (MBRX) — Frequently Asked Questions
Moleculin Biotech Inc. (MBRX) is a publicly traded US company. It has a market capitalization of $8M. Explore MBRX's stock price, financial statements, earnings history, margins and key ratios below.
What is Moleculin Biotech Inc.'s market cap?
Moleculin Biotech Inc. (MBRX) has a market capitalization of $8M.
What is the MBRX stock price?
MBRX trades at $2.50 (+3.73% on the day).
Is MBRX profitable?
In fiscal 2025, Moleculin Biotech Inc. reported net income of -$34M.